Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

301.81
+6.812.31%
Post-market: 301.810.00000.00%19:30 EDT
Volume:183.05K
Turnover:55.21M
Market Cap:6.02B
PE:31.08
High:304.78
Open:294.79
Low:294.32
Close:295.00
52wk High:326.63
52wk Low:175.89
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.81
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:6.22
PE(LYR):49.23

Loading ...

Ligand Pharmaceuticals Incorporated - Buys Rights to Royalty and Milestone Payments on Ryjunea in Emea

THOMSON REUTERS
·
Sep 22

Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

THOMSON REUTERS
·
Sep 22

Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)

TIPRANKS
·
Sep 22

Ligand CLO, Secretary Andrew Reardon Sells USD 1.43 Million in Common Shares

Reuters
·
Sep 09

Is Ligand Pharmaceuticals (LGND) Undervalued On Its Conference Appearance?

Simply Wall St.
·
Aug 30

Ligand Targets $150-$250 Million in Annual Investments as Royalty Revenue Tops $225 Million in 2026 Guidance

Reuters
·
Aug 26

Ligand Management Participates in Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Aug 26

Reaffirmed 2026 Guidance After Strong Q2 Could Be A Game Changer For Ligand Pharmaceuticals (LGND)

Simply Wall St.
·
Aug 19

Ligand Pharmaceuticals Price Target Announced at $330.00/Share by Leerink Partners

Dow Jones
·
Aug 15

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Reuters
·
Aug 08

Ligand Pharmaceuticals Price Target Raised to $345.00/Share from $340.00 by RBC Capital

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AMN Healthcare Services (AMN) and Warby Parker (WRBY)

TIPRANKS
·
Aug 08

RBC Adjusts PT on Ligand Pharmaceuticals to $345 From $340, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Ligand Pharmaceuticals (LGND) Posts Strong Q2 Results, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 07

Halozyme Q2 Revenue Jumps 48%, Raises 2026 Outlook

Reuters
·
Aug 07

Ligand Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Protagonist Therapeutics (PTGX) and Zoetis (ZTS)

TIPRANKS
·
Aug 07

Ligand Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $358 from $289

THOMSON REUTERS
·
Aug 06

Cancer Drugmaker Genmab's H1 Revenue Rises, Lifts FY Outlook

Reuters
·
Aug 06

Ligand Pharmaceuticals Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06